We are live on
!
Find out more
Acadian Asset Management Portfolio holdings
AUM
$70.5B
1-Year Est. Return
36%
This Fund
S&P 500
This Quarter
Est. Return
+1.38%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$23.9B
AUM Growth
-$469M
(-1.9%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.61%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
1,935
New
209
Increased
532
Reduced
683
Closed
293
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$392M |
| 2 |
BP
BP
|
+$158M |
| 3 |
General Motors
GM
|
+$152M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$148M |
| 5 |
Amdocs
DOX
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$102M |
| 2 |
Marriott International
MAR
|
+$95.6M |
| 3 |
Fortinet
FTNT
|
+$94.9M |
| 4 |
Cardinal Health
CAH
|
+$91.3M |
| 5 |
Apple
AAPL
|
+$88.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.31% |
| 2 | Consumer Discretionary | 13.19% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Staples | 10.22% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
iShares MSCI EAFE ETF
EFA
$79.9B
| $3.76M | 0.02% |
54,592
+3,717
| +7% | +$266K |
|
|
EGRX
527
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.73M | 0.02% |
236,902
+12,326
| +5% | +$221K |
|
528
Qfin Holdings
QFIN
$1.56B
| $3.73M | 0.02% |
243,365
+224,779
| +1,209% | +$3.84M |
|
529
Amcor
AMCR
$21.9B
| $3.65M | 0.02% |
79,776
-516,676
| -87% | -$24.9M |
|
530
Accenture
ACN
$110B
| $3.61M | 0.02% |
11,751
-54
| -0.5% | -$17K |
|
531
Emerson Electric
EMR
$91.7B
| $3.61M | 0.02% |
37,390
+3,317
| +10% | +$316K |
|
|
AMWD
532
DELISTED
American Woodmark
AMWD
| $3.6M | 0.02% |
47,613
+31,406
| +194% | +$2.36M |
|
533
Tactile Systems Technology
TCMD
$545M
| $3.58M | 0.02% |
255,057
-252,913
| -50% | -$4.95M |
|
534
Movado Group
MOV
$822M
| $3.58M | 0.02% |
130,883
-83,347
| -39% | -$2.27M |
|
535
Iron Mountain
IRM
$36.4B
| $3.57M | 0.01% |
60,030
+7,445
| +14% | +$455K |
|
536
eHealth
EHTH
$39.1M
| $3.56M | 0.01% |
481,454
+98,338
| +26% | +$773K |
|
|
MAGN
537
Magnera Corp
MAGN
$444M
| $3.55M | 0.01% |
136,647
-2,520
| -2% | -$83.9K |
|
538
Oscar Health
OSCR
$8.63B
| $3.55M | 0.01% |
637,475
| – | – |
|
|
MCBC
539
DELISTED
Macatawa Bank Corp
MCBC
| $3.55M | 0.01% |
396,277
-18,186
| -4% | -$170K |
|
540
Cardlytics
CDLX
$22.4M
| $3.55M | 0.01% |
21,505
+4,140
| +24% | +$538K |
|
541
Relmada Therapeutics
RLMD
$477M
| $3.51M | 0.01% |
1,172,723
-48,676
| -4% | -$145K |
|
542
Information Services Group
III
$250M
| $3.49M | 0.01% |
797,086
-234,137
| -23% | -$1.17M |
|
543
ConocoPhillips
COP
$151B
| $3.46M | 0.01% |
28,922
-1,828
| -6% | -$212K |
|
544
Hyster-Yale Materials Handling
HY
$619M
| $3.46M | 0.01% |
77,593
-29,679
| -28% | -$1.37M |
|
|
NSTG
545
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.44M | 0.01% |
2,003,708
+967,219
| +93% | +$2.94M |
|
546
Biogen
BIIB
$30.1B
| $3.42M | 0.01% |
13,325
-32,715
| -71% | -$8.75M |
|
547
CytomX Therapeutics
CTMX
$752M
| $3.41M | 0.01% |
2,646,190
-7,386
| -0.3% | -$11.6K |
|
|
BLD
548
DELISTED
TopBuild
BLD
| $3.41M | 0.01% |
13,562
+11,030
| +436% | +$3.04M |
|
549
Arch Capital
ACGL
$33.5B
| $3.38M | 0.01% |
42,507
+42,161
| +12,185% | +$3.28M |
|
550
Kulicke & Soffa
KLIC
$4.76B
| $3.29M | 0.01% |
67,742
-19,150
| -22% | -$1.02M |
|
Similar funds
BC
Acadian Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Acadian Asset Management held 1,935 positions worth $23.9B, down 1.9% from $24.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Acadian Asset Management's Q3 2023 filing shows 209 new, 532 increased, 683 reduced and 293 closed positions. Its largest new stake was Amdocs: 1,147,499 shares worth $96.9M. The largest sale was GSK, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Acadian Asset Management's largest Q3 2023 buy was Amdocs: 1,147,499 shares worth $96.9M.
- Acadian Asset Management added most to Stellantis in Q3 2023, an estimated $392M increase.
- Acadian Asset Management's biggest Q3 2023 reduction was GSK, cutting an estimated $102M.
- Acadian Asset Management fully exited KE Holdings in Q3 2023, selling an estimated $49.5M.
- Acadian Asset Management's ten largest holdings make up 21% of its $23.9B portfolio in Q3 2023.
- Acadian Asset Management opened 209 new positions and closed 293 in Q3 2023.
- Acadian Asset Management's portfolio value fell 1.9% quarter-over-quarter to $23.9B.
Based on Acadian Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.